AI-generated summaries. Not legal advice. Always verify against the official judgment on NSW Caselaw.
← All decisions
District Court 24 October 2025

R v Catanuto

[2025] NSWDC 520

Drugs
CRIME DRUG OFFENCES SENTENCE METHYLAMPHETAMINE) “HUGE” QUANTITIES OF INDIVIDUAL DRUGS ROLE OF OFFENDER

Citation: R v Catanuto [2025] NSWDC 520
Court: District Court of NSW
Date: 24 October 2025
Judge: King SC DCJ

Background

The offender, a resident of a property in Mortdale, faced sentence on three serious drug offences following a police investigation involving extensive physical surveillance across July to September 2023. His home formed the primary site of a clandestine drug manufacturing operation, and a storage unit he had leased since 2016 in Kirrawee was used to store precursor chemicals. A co-offender, who was not before the court at this hearing, was also involved in the operation.

Police searched the Mortdale premises on 13 September 2023 and uncovered a clandestine laboratory containing large quantities of MDMA and methylamphetamine in various stages of manufacture. The Kirrawee storage unit, searched two days later, yielded approximately 215 kilograms of 1,4-butanediol, a precursor chemical, concealed in bottles labelled "Rose Hydrosol."

The offender was arrested on 13 September 2023 and had remained in continuous custody since that date. He was committed for sentence in June 2025 after entering guilty pleas, which attracted a 25 percent discount on each offence.

  • The appropriate head sentence and non-parole period for each of three offences, each carrying a maximum of life imprisonment and a standard non-parole period of 15 years
  • The offender's role and level of culpability within the broader operation
  • The objective seriousness of offences involving "huge" quantities of prohibited drugs
  • Whether subjective factors, including a guilty plea, first-time custody, and early rehabilitation steps, warranted mitigation
  • Whether special circumstances existed to justify varying the statutory relationship between the non-parole period and the total sentence
  • How the totality principle should apply when imposing an aggregate sentence across three serious offences

Decision

His Honour found the offences to be of very high objective seriousness. The quantities involved were described as "huge": 30.46 kilograms of MDMA, 11 kilograms of methylamphetamine, and 223.5 kilograms of 1,4-butanediol, all exceeding the "large commercial quantity" threshold. The Mortdale premises functioned as a functioning clandestine laboratory, and the offender was the primary resident. His storage unit had been used to house precursor chemicals for several years.

The offender's account of his involvement was considered, as were his subjective circumstances. He was a first-time offender who had cooperated with police in interview and had begun attending Narcotics Anonymous meetings while on remand. A 25 percent discount for the early guilty plea was applied to each offence.

His Honour declined to find special circumstances to vary the statutory non-parole period ratio. Although the offender's first time in custody was acknowledged, King SC DCJ noted that this factor alone does not establish special circumstances. The balance of term (four years and six months) already exceeded the three-year supervision period ordinarily available on parole, and the offender had access to rehabilitation programmes during the custodial period.

Applying the totality principle, His Honour imposed an aggregate sentence of 18 years' imprisonment with a non-parole period of 13 years and six months, backdated to the date of arrest.

Orders Made

  • Aggregate sentence of 18 years' imprisonment imposed
  • Non-parole period of 13 years and six months
  • Balance of term: 4 years and 6 months
  • Sentence backdated to 13 September 2023 (date of arrest)
  • First eligible for parole: 12 March 2037
  • Total sentence expires: 12 September 2041
  • Indicative sentence for Sequence 4 (MDMA manufacture): 15 years, non-parole period 11 years and 3 months
  • Indicative sentence for Sequence 7 (1,4-butanediol supply, with Form 1 cocaine matter): 15 years, non-parole period 11 years and 3 months
  • Indicative sentence for Sequence 9 (methylamphetamine manufacture): 14 years, non-parole period 10 years and 6 months
  • 25 percent discount applied to each offence for guilty plea

Key Takeaways

  • The District Court confirmed that drug offences involving quantities well in excess of the "large commercial quantity" threshold, coupled with a functioning clandestine laboratory, will be assessed as objectively very serious, attracting indicative head sentences at or near the standard non-parole period benchmark.
  • A first-time offender in custody does not automatically satisfy the test for special circumstances; the court must be satisfied that the statutory non-parole period ratio genuinely fails to accommodate rehabilitation needs given the individual's circumstances.
  • Under the totality principle, an aggregate sentence may sit below the sum of the individual indicative sentences where multiple serious offences arise from the same ongoing operation.
  • Early guilty pleas, cooperation with police, and commencement of rehabilitation programmes (here, Narcotics Anonymous attendance on remand) were recognised as mitigating factors, but their weight was limited given the scale and seriousness of the conduct.
  • Where precursor chemicals are stored by an offender over an extended period and a clandestine laboratory is operated from the offender's own residence, those features bear significantly on the assessment of both objective seriousness and the offender's role.

Legislation and Cases Referenced

Legislation:
- Drugs Misuse and Trafficking Act 1985 (NSW), ss 24(2), 25(2)

Cases:
No cases were cited in the material provided.